EPP is only the tip of the iceberg in terms of indications this drug can address. It is is a first in class drug that could revolutionise the treatment of a whole raft of conditions. I’d watch this space very carefully over the next 6 to 24 months - likely to be a very different beast over that time.
Price targets, page-6
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.72 |
Change
-0.100(0.67%) |
Mkt cap ! $737.1M | |||
| Open | High | Low | Value | Volume |
| $14.80 | $14.97 | $14.60 | $600.3K | 40.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 324 | $14.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.75 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |